• Ingen resultater fundet

Danish Cancer Society Symposium Cardiotoxicity in cancer survivors

N/A
N/A
Info
Hent
Protected

Academic year: 2022

Del "Danish Cancer Society Symposium Cardiotoxicity in cancer survivors"

Copied!
3
0
0

Indlæser.... (se fuldtekst nu)

Hele teksten

(1)

1

Danish Cancer Society Symposium

Cardiotoxicity in cancer survivors

Achieving cure without a broken heart

Preliminary Scientific Programme

Monday, 16 June 2014 Speaker

08.30 – 09.00 Registration

09:00 – 09:15 Welcome Organizers

Session 1: Incidence and prevalence

09.15 – 10.15 Keynote lecture Sarah Darby

Epidemiology: Cardiotoxicity in cancer survivors

10.15 – 10.45 Coffee break

Session 2: Mechanisms of cardiotoxicity

10.45 – 11.30 Biology: Mechanisms of radiation damage to the heart Klaus Trott 11.30 – 12.15 Cardiology: Clinical manifestations of cardiac toxicity Merete V Nilsen

12.15 – 12.30 Panel discussion Chair: Lena Specht

12.30 – 13.30 Lunch

13.30 – 14.30 Guided poster walk

Session 3: Risk factors

14.30 – 15.15 Cardiovascular risk in multi-modality treatments:

A review of current evidence Andrea Ng

15.15 – 16:00 Children, adolescents and young adults:

A special risk group Louis S Constine

16.00 – 16.30 Panel discussion Chair: Maja Maraldo

16.30 – 18.30 Welcome reception

(2)

Tuesday, 17 June 2014 Speaker

Session 4: Predictive models and epidemiological data

09.00 – 09.45 Predictive models: assessing the risk of Peter van Luijk cardiotoxicity prior to treatment

09.45 – 10.30 Gathering epidemiological data as input to predictive

Models: What are the missing links? Søren Bentzen

10.30 – 11.00 Coffee break

11.00 – 12.00 Keynote lecture: Beyond mean heart dose Marianne Ewertz What is the best predictor of late cardiac toxicity?

12.00 – 12.30 Panel discussion Chair: Ivan Vogelius

12.30 – 13.30 Lunch

13.30 – 14.30 Guided poster walk

Session 5: Detection and follow up

14.30 – 15.15 Imaging: early detection of cardiotoxicity Philip Hasbak

15.15 – 16.00 Early endpoints: how and when to image? Lawrence Marks How can early endpoints be used to improve current treatments

16.00 – 16.30 Coffee break

16.30 – 17.15 Survivorship: practical considerations for the follow up Berthe Aleman of cancer survivors

17.15 – 17.45 Panel discussion Chair: Marianne Aznar

19.30 Dinner

(3)

Wednesday, 18 June 2014 Speaker

09.00 – 09.15 Presentation of poster awards

Session 6: Prevention and management of cardiotoxicity

09.15 – 10.00 Stem cells in the treatment of cardiotoxicity: Jens Kastrup Is it an option for cancer patients?

10.00 – 10.45 Managing cardiotoxicity in modern systemic cancer treatment Daniela Cardinale

10.45 – 11.15 Coffee break

11:15 – 12.00 Technological advances to spare the heart: How to select Anders Pedersen patients and offer value to health care providers?

12.00 – 12.20 Final panel discussion Peter M Petersen

12.20 – 12.30 Closing words from the organizing committee

12.30 Lunch and departure

Referencer

RELATEREDE DOKUMENTER

[r]

Danish Cancer Society Research Center, DCRC.

Four years ago, the Danish Cancer Society laid down the first brick of a new, significant pillar in the organisation’s research support when DKK 8 million from the 2016 Knæk

to the cancer survivors and the health care professionals who shared their experiences with us and to the Danish Milieu of. Humanistic Cancer Research for

Kilde: American Cancer Society/American Society of Clinical Omcology Breast Cancer Survivorship Care Guideline.. Runowics

To evaluate the quality of the modernized DCR, The National Board of Health, the Danish Cancer Society and representatives from the Danish Lung Cancer Group (DLCG) and Danish

Jacques Pouyssegur, France Lorenz Poellinger, Sweden Margaret Ashcroft, UK Marja Jäättelä, Denmark. Oluf Borbye Pedersen, Denmark Peter Friedl, the Netherlands Robert

Funded by: Danish Cancer Society | The Novo Nordisk